Compare Brevis (BREV) vs Immunefi (IMU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Immunefi — how do they compare? Brevis trades at Rp1,181 (market cap Rp295,11M, Rp183,34M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Brevis is far larger — about 10.9× Immunefi's market cap, and Brevis's circulating supply is 250M / 1B BREV (25%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 8 Days and Immunefi for 5 Days on average.
| BREV | IMU | |
|---|---|---|
Market Cap | Rp295,11M | Rp27,03M |
Volume (24h) | Rp183,34M | Rp39,91M |
Circulating Supply | 250M / 1B BREV (25%) | 873,4M / 10B IMU (9%) |
Typical Hold Time | 8 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Brevis (BREV) is trading at Rp1,215.88 with a market cap of Rp304.38 million, showing a bearish technical signal as moving averages indicate strong selling pressure while oscillators remain neutral. The current price sits just below the pivot point of Rp1,219, with immediate support at Rp1,203 and resistance at Rp1,237. No recent protocol updates or ecosystem news are available, and the token has a low circulation rate of 25% with a max supply of 1 million tokens.
Overall outlook is cautious due to bearish technicals and limited liquidity. Key opportunities include potential rebounds from oversold RSI levels, but major risks involve low trading volume, high volatility, and lack of recent development activity, making it susceptible to price swings.
IMU token shows limited market activity with a modest market cap of Rp27.03M and only 9% circulating supply. The token exhibits low trading volume and minimal network activity, with a short average hold time of 5 days indicating speculative trading patterns. Recent coverage appears to confuse this cryptocurrency with a corporate entity, creating market confusion.
Outlook remains cautious due to extremely low liquidity and market confusion with traditional equity. Key risk is entity misidentification impacting proper valuation. Opportunity exists if protocol utility develops, but current fundamentals are weak with minimal ecosystem activity.
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
